These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 35177180

  • 1. Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: a prospective randomized controlled trial.
    Liu MM, Ji L, Dong MY, Zhu XF, Wang HJ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jan 15; 24(1):78-84. PubMed ID: 35177180
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D.
    Neonatology; 2015 Jan 15; 107(4):358-9. PubMed ID: 26044104
    [Abstract] [Full Text] [Related]

  • 4. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY, Li JC, Liu YL, Zhao XB, Male M, Song DK, Bai Y.
    Curr Med Sci; 2019 Jun 15; 39(3):493-499. PubMed ID: 31209823
    [Abstract] [Full Text] [Related]

  • 5. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.
    Yeh TF, Chen CM, Wu SY, Husan Z, Li TC, Hsieh WS, Tsai CH, Lin HC.
    Am J Respir Crit Care Med; 2016 Jan 01; 193(1):86-95. PubMed ID: 26351971
    [Abstract] [Full Text] [Related]

  • 6. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R, Kamaluddeen M, Hasan SU, Robertson HL, Lodha A.
    Pediatr Pulmonol; 2017 Jul 01; 52(7):968-975. PubMed ID: 28165675
    [Abstract] [Full Text] [Related]

  • 7. The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial.
    Marzban A, Mokhtari S, Tavakkolian P, Mansouri R, Jafari N, Maleki A.
    BMC Pediatr; 2024 Apr 20; 24(1):262. PubMed ID: 38643076
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: a comparative analysis].
    Ke H, Li ZK, Yu XP, Guo JZ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 May 20; 18(5):400-4. PubMed ID: 27165587
    [Abstract] [Full Text] [Related]

  • 10. Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia.
    Heo M, Jeon GW.
    Turk J Pediatr; 2020 May 20; 62(4):551-559. PubMed ID: 32779407
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
    Xu H, Xu P.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb 20; 33(2):174-179. PubMed ID: 33729136
    [Abstract] [Full Text] [Related]

  • 12. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL, McKinlay CJD, Kamlin COF, Cheong JLY, Dargaville PA, Dawson JA, Doyle LW, Jacobs SE, Davis PG, Donath SM, Manley BJ.
    Trials; 2023 Nov 06; 24(1):709. PubMed ID: 37932774
    [Abstract] [Full Text] [Related]

  • 13. Intratracheal Instillation of Budesonide-Surfactant for Prevention of Bronchopulmonary Dysplasia in Extremely Premature Infants.
    Dolma K, Zayek M, Gurung A, Eyal F.
    Am J Perinatol; 2024 May 06; 41(S 01):e3065-e3073. PubMed ID: 37913780
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis.
    Tang W, Chen S, Shi D, Ai T, Zhang L, Huang Y, Fan Y, Du Y.
    Pediatr Pulmonol; 2022 Feb 06; 57(2):455-469. PubMed ID: 34783192
    [Abstract] [Full Text] [Related]

  • 15. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J, Bao Y, Du L, Huang H, Lv Q, Jiang Y, Dai Y, Chen Z, Shi J, Shi Y, Yang C, Mei H, Jiang H, Sun Y, Sun X.
    Trials; 2020 Jun 11; 21(1):516. PubMed ID: 32527290
    [Abstract] [Full Text] [Related]

  • 16. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC, Bao YY, Zhao JX, Cheng K, Sun L, Wu JY, Wu MY, Zhu JJ.
    BMC Pulm Med; 2022 Dec 05; 22(1):462. PubMed ID: 36471386
    [Abstract] [Full Text] [Related]

  • 17. Long-term Effects of Intratracheal Budesonide and Surfactant for the Prevention of Bronchopulmonary Dysplasia: A Narrative Review.
    Nobile S, Di Sipio Morgia C, Hall M.
    Am J Perinatol; 2024 May 05; 41(S 01):e1858-e1865. PubMed ID: 37279790
    [Abstract] [Full Text] [Related]

  • 18. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS, Ohlsson A, Halliday HL, Shah VS.
    Cochrane Database Syst Rev; 2017 Oct 17; 10(10):CD002058. PubMed ID: 29041034
    [Abstract] [Full Text] [Related]

  • 19. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP, Blennow M, Soll RF.
    Cochrane Database Syst Rev; 2002 Oct 17; (2):CD003063. PubMed ID: 12076469
    [Abstract] [Full Text] [Related]

  • 20. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kanmaz Kutman HG, Cetinkaya M, Kornhauser-Cerar L, Derrick M, Özkan H, Hulzebos CV, Schmölzer GM, Aiyappan A, Lemyre B, Kuo S, Rajadurai VS, O'Shea J, Biniwale M, Ramanathan R, Kushnir A, Bader D, Thomas MR, Chakraborty M, Buksh MJ, Bhatia R, Sullivan CL, Shinwell ES, Dyson A, Barker DP, Kugelman A, Donovan TJ, Tauscher MK, Murthy V, Ali SKM, Yossuck P, Clark HW, Soll RF, Carlin JB, Davis PG, OPTIMIST-A Trial Investigators.
    JAMA; 2021 Dec 28; 326(24):2478-2487. PubMed ID: 34902013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.